60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Interest Expense : $-1.15 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. 60 Degrees Pharmaceuticals's interest expense for the three months ended in Mar. 2024 was $ -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.15 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. 60 Degrees Pharmaceuticals's Operating Income for the three months ended in Mar. 2024 was $ -1.33 Mil. 60 Degrees Pharmaceuticals's Interest Expense for the three months ended in Mar. 2024 was $ -0.00 Mil. 60 Degrees Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

60 Degrees Pharmaceuticals Interest Expense Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals Interest Expense Chart

60 Degrees Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-2.68

-3.17

-3.99

-2.29

60 Degrees Pharmaceuticals Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial							-1.14	-1.10	-0.04	-0.01	-

60 Degrees Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.15 Mil.

60 Degrees Pharmaceuticals (NAS:SXTPW) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

60 Degrees Pharmaceuticals's Interest Expense for the three months ended in Mar. 2024 was $-0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-1.33 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.15 Mil.

60 Degrees Pharmaceuticals's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

60 Degrees Pharmaceuticals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

SXTP:USA

Address

1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036

Website

https://www.60degreespharma.com

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.